Sensitivity Comparison of Follow-up MRI Between Acute Cerebral and Cerebellar Cortical Microinfarctions ( CMI )Microinfarctions

Last updated: March 28, 2024
Sponsor: Centre Hospitalier Universitaire de Nīmes
Overall Status: Active - Recruiting

Phase

N/A

Condition

Allergy (Pediatric)

Allergies & Asthma

Allergy

Treatment

None, purely observational study

Clinical Study ID

NCT06218576
LOCAL/2023/DR-01
  • Ages > 18
  • All Genders

Study Summary

Cerebral cortical microinfarctions (CMI) are frequently observed on MRI and histology studies, especially in elderly patients and in patients with cognitive dysfunction. The majority of these studies analysed chronic cerebral CMI lesions.

The few studies reporting on temporal dynamics of MRI signal of acute cerebral CMI showed very low sensibility for persisting signal changes on follow-up MRI on standard MRI sequences. A retrospective study, analysing follow-up 3T MRI in 25 patients with acute cerebral CMI (defined as ≤10 mm on DWI), showed a chronic cerebral CMI detection rate of only 16% on T2-weighted and 5% on FLAIR imaging after a mean follow-up period of 33 months (with a very wide range of 0.5-142 months). Another 3T MRI study including seven patients showed disappearance of all acute cerebral very small-sized CMI (defined as <5 mm size on initial DWI) on all follow-up MRI sequences (T1- and T2-weighted and FLAIR imaging, performed after one month).

Recently, it has been shown that chronic relatively small (<20 mm) cerebellar cortical infarctions (based on diffusion-weighted imaging) were frequently observed in acute stroke patients, especially in case of cardioembolic stroke (with chronic small cerebellar cortical infarctions observed in 32% of cases). The high prevalence of these chronic small cerebellar cortical infarctions suggest a possible higher detection rate of chronic small-sized infarction in the cerebellum compared to the supratentorial brain.

Eligibility Criteria

Inclusion

Inclusion Criteria: Patients admitted to our stroke centre between February 2021 and June 2023 with thefollowing inclusion criteria:

  • age >18 years,
  • initial MRI performed within one week after symptom onset,
  • symptomatic brain infarction confirmed by DWI,
  • presence of acute cerebral and/or cerebellar CMI

Exclusion

Exclusion Criteria:

  • age < 18 years

Study Design

Total Participants: 59
Treatment Group(s): 1
Primary Treatment: None, purely observational study
Phase:
Study Start date:
February 15, 2024
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • CHU de Nîmes

    Nîmes, 30029
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.